Skip to main content

Jonathan Edward Campbell

Associate Professor in Medicine
Medicine, Endocrinology, Metabolism, and Nutrition

Selected Grants


Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Alpha- to Beta-Cell Communication in Health and Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia

ResearchMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2022 - 2027

Training Program in Developmental and Stem Cell Biology

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027

Novel assays for proglucagon peptides to understand alpha cell function in health and diabetes

ResearchPrincipal Investigator · Awarded by Leona M. and Harry B. Helmsley Charitable Trust · 2024 - 2026

The role of ubiquitination in glucagon-induced signaling bias and insulin secretion

ResearchCollaborating Investigator · Awarded by American Heart Association · 2023 - 2026

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Preclinical studies to gain mechanistic insight into how Rejuva regulates islet function

ResearchPrincipal Investigator · Awarded by Fractyl Health · 2025 - 2026

Engineered Glucose Metabolism in Insulin Secreting Cells

ResearchCo Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2002 - 2026

Leveraging glucagon activity to target hepatic steatosis, fibrosis, and inflammation

ResearchPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2022 - 2025

Effects of NutraMeta during and following GLP-1R-mediated weight loss

ResearchPrincipal Investigator · Awarded by Prostasis, LLC · 2024 - 2025

Structure Therapeutics - Incretin small molecules

ResearchPrincipal Investigator · Awarded by Structure Therapeutics Inc. · 2024 - 2025

Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment

ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025

Novel metabolic actions of GIP

ResearchPrincipal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2020 - 2025

Alticor Research Project: Testing compounds derived from botanicals for activity at the GLP-1R in mouse islets

ResearchPrincipal Investigator · Awarded by Alticor Global Holdings Inc · 2023 - 2024

ELI Lilly SRA

ResearchPrincipal Investigator · Awarded by Eli Lilly and Company · 2019 - 2024

Mechanisms of insulin secretion mediated by alpha cells

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024

Protasis

ResearchPrincipal Investigator · Awarded by Prostasis, LLC · 2018 - 2023

Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism

ResearchMentor · Awarded by National Institutes of Health · 2021 - 2023

The Role of Islet DPP4 for Regulation of Glucose Homeostasis

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2018 - 2021

External Relationships


  • American Diabetes Association
  • Arrowhead Pharmaceutical Inc.
  • Boehringer Ingelheim
  • Prostasis
  • Protagonist Therapeutics
  • Septerna
  • Structure Therapeutics

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.